IPMN |
Intraductal papillary mucinous neoplasm |
CT |
Computed tomography |
MRI |
Magnetic resonance imaging |
MRCP |
Magnetic resonance cholangiopancreatography |
PDAC |
Pancreatic ductal adenocarcinoma |
ICG |
International consensus guidelines |
MD-IPMN |
Main duct IPMN |
BD-IPMN |
Branch duct IPMN |
MPD |
Main pancreatic duct |
AGA |
American Gastroenterological Association |
EUS |
Endoscopic ultrasound |
FNA |
Fine needle aspiration |
HGD |
High-grade dysplasia |
CEA |
Carcinoembryonic antigen |
SCA |
Serous cystadenoma |
SPN |
Solid pseudo-papillary neoplasm |
MCN |
Mucinous cystic neoplasm |
GNAS |
Guanine nucleotide binding protein, alpha-stimulating |
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
NGAL |
neutrophil gelatinase-associated lipocalin |
MUC |
Mucin |
IL |
Interleukin |
PGE2 |
Prostaglandin E2 |
ELISA |
Enzyme-linked immunosorbent assay |
NSAID |
Nonsteroidal anti-inflammatory drug |
LGD |
Low-grade dysplasia |
miRNA |
MicroRNA |
NGS |
Next Generation Sequencing |
mAb |
Monoclonal antibody |
CEP |
Colon epithelial protein |
PCR |
Polymerase chain reaction |
LOH |
Loss of heterozygosity |
MOCA |
Multivariate organization of combinatorial alterations |
IMP |
Integrated molecular pathology |
PANCAN |
Pancreatic Cancer Action Network |
NCI |
National Cancer Institute |